TruScreen Group Limited (NZE:TRU)

New Zealand flag New Zealand · Delayed Price · Currency is NZD
0.0170
0.00 (0.00%)
At close: Mar 4, 2026
-45.16%
Market Cap 12.70M
Revenue (ttm) 1.82M
Net Income (ttm) -2.47M
Shares Out 747.33M
EPS (ttm) -0.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 463,221
Average Volume 951,535
Open 0.0170
Previous Close 0.0170
Day's Range 0.0170 - 0.0170
52-Week Range 0.0160 - 0.0330
Beta -0.13
RSI 41.07
Earnings Date Feb 27, 2026

About TruScreen Group

TruScreen Group Limited, together with its subsidiaries, develops, manufacture, and sale of cancer detection devices and systems in Mexico, China, Russia, Vietnam, Zimbabwe, and the Middle East/North Africa. It offers the TruScreen cervical cancer screening device, a medical device for identifying and detecting the presence of precancerous and cancerous tissue on the cervix in real time. The company was formerly known as TruScreen Limited and changed its name to Truscreen Group Limited in August 2020. TruScreen Group Limited was incorporated in... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2013
Country New Zealand
Stock Exchange New Zealand Stock Exchange
Ticker Symbol TRU
Full Company Profile

Financial Performance

In fiscal year 2025, TruScreen Group's revenue was 2.07 million, a decrease of -20.28% compared to the previous year's 2.60 million. Losses were -2.24 million, 9.41% more than in 2024.

Financial Statements

News

There is no news available yet.